Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:30 PM ET Form 4
Insider Buying Hyperscale Data, Inc. GPUS

Hyperscale Data CEO William B. Horne Buys $16.3K of Stock

William B. Horne, CEO, bought 100,000 shares of Hyperscale Data, Inc. at $0.163 a share, worth $16.3K in total on Sep 30, 2026. Shares held after the trade: 500,000 (+25.0%).

Value
$16.3K
Shares
100,000
Price
$0.1630
Role
CEO
Holding change
+25.0%
Trade date
Sep 30, 2026
4:30 PM ET Form 4
Insider Selling Airbnb, Inc. ABNB

Airbnb Chief Strategy Officer Nathan Blecharczyk Sells $2.14M of Stock

Nathan Blecharczyk, Chief Strategy Officer, sold 13,615 shares of Airbnb, Inc. at $154.45 to $158.31 a share (average $156.82) in 5 transactions, worth $2.14M in total on Sep 28, 2026. Shares held after the trade: 20,567 (-0.6%).

Value
$2.14M
Shares
13,615
Average price
$156.82
Role
Chief Strategy Officer
Holding change
-0.6%
Trade date
Sep 28, 2026
4:30 PM ET Form 4
Insider Selling BioNTech SE BNTX

BioNTech CEO Ugur Sahin Sells $6.48M of Stock

Ugur Sahin, CEO, sold 66,000 shares of BioNTech SE at $98.12 to $98.26 a share (average $98.19) in 2 transactions, worth $6.48M in total between Sep 29, 2026 and Sep 30, 2026. Shares held after the trade: 214,209 (-13.0%).

Value
$6.48M
Shares
66,000
Average price
$98.19
Role
CEO
Holding change
-13.0%
Trade date
Sep 29, 2026 to Sep 30, 2026
4:29 PM ET Form 4
Insider Selling Park Ohio Holdings Corp PKOH

Park Ohio Holdings Secretary & CLO Robert D. Vilsack Sells $369K of Stock

Robert D. Vilsack, Secretary & CLO, sold 7,781 shares of Park Ohio Holdings Corp at $47.27 to $47.70 a share (average $47.43) in 17 transactions, worth $369K in total on Sep 28, 2026. Shares held after the trade: 173,042 (-0.3%).

Value
$369K
Shares
7,781
Average price
$47.43
Role
Secretary & CLO
Holding change
-0.3%
Trade date
Sep 28, 2026
4:29 PM ET Form 4
Insider Buying Kodiak Sciences Inc. KOD

Kodiak Sciences Director Baker Bros. Advisors LP Buys $58.6M of Stock

Baker Bros. Advisors LP, Director, bought 807,840 shares of Kodiak Sciences Inc. at $61.21 to $78.57 a share (average $72.57) in 30 transactions, worth $58.6M in total on Sep 28, 2026. Shares held after the trade: 18,435,276 (+0.0%).

Value
$58.6M
Shares
807,840
Average price
$72.57
Role
Director
Holding change
+0.0%
Trade date
Sep 28, 2026
4:29 PM ET 8-K
Dividend Antares Strategic Credit Fund II LLC

Antares Strategic Credit Fund II Dividend

Antares Strategic Credit Fund II LLC declared a regular and special distribution totaling $0.1785 per share for its common shares, payable on October 28, 2026. The filing also provided a monthly update on its net asset value (NAV) per share, which was $24.82 as of August 31, 2026, and noted $7.9 million in new subscriptions received during the period.

4:28 PM ET 8-K
Dividend Antares Private Credit Fund

Antares Private Credit Fund Dividend

Antares Private Credit Fund declared a regular monthly distribution of $0.1827 per share for its common shares, payable on October 28, 2026, to shareholders of record as of September 29, 2026. The company also reported a Net Asset Value (NAV) per share of $24.70 as of August 31, 2026, with an aggregate NAV of approximately $820.9 million.

4:27 PM ET 8-K/A
Executive Compensation Innodata Inc INOD

Innodata Executive Compensation

Innodata Inc. entered into employment agreement amendments for Jack S. Abuhoff and Rahul Singhal to formalize their leadership transitions effective September 30, 2026. Mr. Abuhoff will transition to Executive Chairman with an annual base salary of $600,000, while Mr. Singhal will become President and CEO with an annual base salary of $636,276, with both executives eligible for a 100% target annual cash bonus.

Counterparty
Jack S. Abuhoff and Rahul Singhal
4:25 PM ET 8-K
Capital Raise Live Oak Acquisition Corp. VI LOVI

Live Oak Acquisition Corp. VI Capital Raise of $230M

Live Oak Acquisition Corp. VI completed its initial public offering (IPO) of 23,000,000 units at $10.00 per unit, raising $230 million in gross proceeds including the full exercise of the over-allotment option. Simultaneously, the company raised an additional $4.6 million through a private placement of warrants to its sponsor. The total proceeds of $230 million have been placed in a trust account as the SPAC seeks a target for a business combination.

Value
$230M
Counterparty
Live Oak Sponsor VI, LLC
4:25 PM ET 8-K
Loan & Debt Park Hotels & Resorts Inc. PK

Park Hotels & Resorts $1.27B Debt Financing with Hilton Hawaiian Village LLC

Park Hotels & Resorts Inc. repaid in full and terminated its $1.275 billion mortgage loan secured by the Hilton Hawaiian Village Waikiki Beach Resort. The repayment was funded using proceeds from a $700 million delayed-draw mortgage financing and a $600 million draw from an unsecured delayed-draw term loan facility. The loan was originally scheduled to mature on November 1, 2026.

Value
$1.27B
Counterparty
Hilton Hawaiian Village LLC
4:23 PM ET Form 4
Insider Selling Bank of New York Mellon Corp BNY

Bank of New York Mellon Senior Executive VP Jose Minaya Sells $520K of Stock

Jose Minaya, Senior Executive VP, sold 3,498 shares of Bank of New York Mellon Corp at $148.34 to $149.27 a share (average $148.78) in 2 transactions, worth $520K in total on Sep 28, 2026. Shares held after the trade: 176,846 (-0.9%).

Value
$520K
Shares
3,498
Average price
$148.78
Role
Senior Executive VP
Holding change
-0.9%
Trade date
Sep 28, 2026
4:23 PM ET 8-K
Shareholder Meeting Angel Oak Financial Strategies Income Term Trust FINS

Angel Oak Financial Strategies Income Term Trust Shareholder Meeting

Angel Oak Financial Strategies Income Term Trust held its 2026 Annual Meeting of Shareholders where investors elected three trustees and ratified Cohen & Company, Ltd. as the independent auditor. Shareholders also approved an amendment to the Declaration of Trust lowering the voting threshold required to remove a trustee for cause from 75% to 66.67%.

4:22 PM ET 8-K
Nasdaq/NYSE Compliance Notice ESS Tech, Inc. GWHTQ

ESS Tech Nasdaq/NYSE Compliance Notice

ESS Tech, Inc. received notice from the NYSE that the exchange has determined to commence delisting proceedings for the company's common stock. The company failed to regain compliance with Section 802.01B, which requires at least $50 million in stockholders' equity or total market capitalization, within the maximum plan period. ESS Tech intends to appeal the determination to a Committee of the Board of Directors of the NYSE.

Counterparty
New York Stock Exchange
4:22 PM ET 8-K
M&A Deal Skydance Corp SKYD

Paramount Skydance M&A Deal with Warner Bros. Discovery, Inc.

Paramount Skydance Corporation and Warner Bros. Discovery (WBD) reached a consent decree with 12 U.S. states, resolving an antitrust lawsuit that sought to enjoin their pending merger. The U.S. District Court for the Northern District of California entered the decree and modified a no-close order, effectively clearing a major regulatory hurdle and permitting the merger to proceed subject to specific film release and theatrical window commitments.

Counterparty
Warner Bros. Discovery, Inc.
Term
5 years
4:21 PM ET Form 4
Insider Buying Primark Meketa Private Equity Investments Fund PMPEX

Primark Meketa Private Equity Investments Fund Insider Peter Scott Woolley Buys $150K of Stock

Peter Scott Woolley bought 8,601 shares of Primark Meketa Private Equity Investments Fund at $17.44 a share, worth $150K in total on Sep 28, 2026. Shares held after the trade: 11,972 (+255.1%).

Value
$150K
Shares
8,600
Price
$17.44
Holding change
+255.1%
Trade date
Sep 28, 2026
4:21 PM ET 8-K
Other 8-K Filing Alamo Group Inc ALG

Alamo Group Other 8-K Filing

Alamo Group Inc. announced it will cease production of its Dixie Chopper branded product line as part of a portfolio review. The company expects to incur total charges between $15.0 million and $20.0 million in the third quarter of 2026, including up to $4.0 million in cash expenditures for inventory returns and contractual commitments.

Counterparty
Dixie Chopper
4:20 PM ET 8-K
Leadership Change Halozyme Therapeutics, Inc. HALO

Halozyme Therapeutics Leadership Change

Halozyme Therapeutics appointed James Daly to its Board of Directors, effective September 28, 2026. Mr. Daly will serve in the class of directors with a term ending at the 2029 annual meeting and will receive standard compensation under the company's non-employee director program.

Counterparty
James Daly
4:20 PM ET 8-K
Financial Results ReposiTrak, Inc. TRAK

ReposiTrak Financial Results

ReposiTrak reported fiscal year 2026 revenue of $23.3 million and GAAP net income of $7.6 million, an 8% increase year-over-year. The company ended the fiscal year with $27.3 million in cash, no bank debt, and returned $5.3 million to shareholders through dividends, preferred share redemptions, and common stock repurchases.

Term
FY2026
Earnings call
Sep 28, 2026, 4:15 PM ET

“We continue to make progress across each of our businesses, while also developing and scaling our new offering with the SPAR Group. Touchless Merchandising leverages ReposiTrak’s technology, identifying supply chain and inventory issues in real time, and SPAR’s field organization, which addresses those issues in the store. Together, we believe this creates an innovative and differentiated scan-based trading solution that can deliver meaningful value to both retailers and brands. Customer interest has been strong, and we have already signed initial agreements with suppliers.”

Randall K. Fields, Chairman and Chief Executive Officer

“Our fiscal 2026 results demonstrate the operating leverage in our business model. Revenue increased 3%, while operating expenses declined 6%, driving a 26% increase in operating income. We also generated $8.2 million in cash from operations and ended the year with more than $27 million in cash and no bank debt. At the same time, we continued to invest in our technology and retu”

Randall K. Fields, Chairman and Chief Executive Officer
4:19 PM ET Form 4
Insider Selling Workday, Inc. WDAY

Workday Insider David A. Duffield Sells $18.7M of Stock

David A. Duffield sold 98,971 shares of Workday, Inc. at $182.67 to $190.60 a share (average $188.55) in 9 transactions, worth $18.7M in total on Sep 28, 2026. Shares held after the trade: 105,049 (-3.6%).

Value
$18.7M
Shares
98,971
Average price
$188.55
Holding change
-3.6%
Trade date
Sep 28, 2026
4:19 PM ET 8-K
Leadership Change Albertsons Companies, Inc. ACI

Albertsons Companies Leadership Change

Albertsons Companies, Inc. appointed William P. Boltz, Chris Drumgoole, and Margaret M. Ham to its Board of Directors, effective October 14, 2026. The appointments expand the board from 11 to 14 members and bring expertise in retail merchandising, technology, and grocery operations to support the company's long-term growth strategy.

4:17 PM ET 8-K
Investor Presentation AIB Data Centers Inc. AIB

AIB Data Centers Investor Presentation

AIB Data Centers Inc. (formerly BlockchAIn Digital Infrastructure, Inc.) released its Q3 2026 investor presentation titled 'Power Meets Execution'. The presentation outlines the company's growth strategy, data center development progress, and power capacity targets, including details regarding its colocation services agreement with Nebius Inc.

4:16 PM ET 8-K
Deal Termination Kulr Technology Group, Inc. KULR

Kulr Technology Group Deal Termination with Cantor Fitzgerald and Craig-Hallum

KULR Technology Group has extended the pause of its at-the-market (ATM) equity offering program with Cantor Fitzgerald and Craig-Hallum through December 31, 2026. This suspension of the capital raise facility indicates the company will not be issuing new shares under the program for the remainder of the year.

Counterparty
Cantor Fitzgerald and Craig-Hallum
Term
through Dec 31, 2026
4:16 PM ET 8-K
Licensing Deal Biomarin Pharmaceutical Inc BMRN

Biomarin Pharmaceutical Licensing Deal with Ascendis Pharma A/S

BioMarin entered into a definitive Settlement and License Agreement with Ascendis Pharma, granting Ascendis a non-exclusive worldwide license to certain patents for the commercialization of TransCon CNP (navepegritide). In exchange, BioMarin will receive royalties of 20% on net sales in the U.S. and 18% in the EU, Brazil, and South Korea through May 2030, while both parties agreed to dismiss all pending patent litigation.

Counterparty
Ascendis Pharma A/S
Term
through May 2030
4:15 PM ET 8-K
Loan & Debt CTO Realty Growth, Inc. CTO

CTO Realty Growth $1B Debt Financing with KeyBank National Association

CTO Realty Growth entered into a $1.0 billion amended and restated unsecured credit facility, increasing its total commitments by $250 million. The facility includes a $400 million revolver and four separate $150 million term loans with maturities ranging from 2029 to 2032, significantly extending the company's weighted average debt maturity to 4.3 years.

Value
$1B
Counterparty
KeyBank National Association
Term
through March 2032
4:15 PM ET 8-K
Loan & Debt Vsee Health, Inc. VSEE

Vsee Health Debt Financing Update with Vanquish

VSee Health issued an additional unsecured convertible promissory note to Vanquish in the principal amount of $180,550, which includes an original issue discount. The note carries a one-time 12% interest charge and is convertible into common stock only upon an event of default at a 35% discount to the market price.

Counterparty
Vanquish
Term
through July 30, 2027
4:15 PM ET 8-K
Business Update Pacific Coast Oil Trust ROYTL

Pacific Coast Oil Trust Business Update

Pacific Coast Oil Trust announced there will be no cash distribution for the month of September 2026 based on net profits generated during July 2026. The Trust noted that future distributions are extremely remote as it faces dissolution due to annual proceeds falling below $2.0 million and ongoing legal proceedings regarding asset retirement obligations.

Counterparty
Pacific Coast Energy Company LP
Term
July 2026
4:15 PM ET 8-K
Business Update MoonLake Immunotherapeutics MLTX

MoonLake Immunotherapeutics Business Update

MoonLake Immunotherapeutics has submitted a Biologics License Application (BLA) to the FDA for its tri-specific nanobody sonelokimab. The application seeks approval for the treatment of moderate-to-severe hidradenitis suppurativa in adults and pediatric patients. The company expects notification regarding the acceptance of the BLA for review within approximately 60 days.

Counterparty
FDA
4:15 PM ET 8-K/A
M&A Deal Bunker Hill Mining Corp. BHLL

Bunker Hill Mining M&A Deal with Silver47 Exploration Corp.

Bunker Hill Mining Corp. filed an amendment to its definitive arrangement agreement to acquire Silver47 Exploration Corp. The amendment corrects the exchange ratio to 0.1724 of a Bunker Hill share for each Silver47 share and clarifies that termination and expense reimbursement fees are denominated in Canadian dollars.

Counterparty
Silver47 Exploration Corp.
4:15 PM ET Form 4
Insider Selling Dexcom Inc DXCM

Dexcom EVP Chief People & Culture Off Sadie Stern Sells $221K of Stock

Sadie Stern, EVP Chief People & Culture Off, sold 2,565 shares of Dexcom Inc at $86.15 a share, worth $221K in total on Sep 28, 2026. Shares held after the trade: 123,478 (-2.0%).

Value
$221K
Shares
2,565
Price
$86.15
Role
EVP Chief People & Culture Off
Holding change
-2.0%
Trade date
Sep 28, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.